BARBARA K FINCK
CIK 1242116 · Chief Medical Officer · last filed 2025-03-21
BARBARA K FINCK is a Chief Medical Officer who has filed 19 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing, for FBRX, was dated Mar 21, 2025. Across all open-market trades the lifetime net is −$110.7K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $54.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$54.3K
3
19
-$110.7K
Holdings By Company
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-03-21 | FBRX | Grant (A) | — | $0 | EDGAR |
| 2024-08-22 | FBRX | Grant (A) | — | $0 | EDGAR |
| 2024-03-25 | FBRX | Grant (A) | — | $0 | EDGAR |
| 2023-09-20 | FBRX | Grant (A) | — | $0 | EDGAR |
| 2023-02-14 | Comera Life Sciences Holdings, Inc. (CMRAW) Delisted | Buy (P) | +6,756 | $8.3K | EDGAR |
| 2023-01-06 | Comera Life Sciences Holdings, Inc. (CMRAW) Delisted | Grant (A) | +6,756 | $8.3K | EDGAR |
| 2022-06-02 | FBRX | Grant (A) | — | $0 | EDGAR |
| 2022-05-16 | FBRX | Grant (A) | — | $0 | EDGAR |
| 2022-03-18 | FBRX | Grant (A) | — | $0 | EDGAR |
| 2018-09-12 | CHRS | Mixed | — | -$30.2K | EDGAR |